Hyung-Jung Pyun

This inventor holds 67 USPTO granted patents and 33 published patent applications, plus 16 CIPO patents and 30 EPO patents, primarily in Antiviral Compounds (CPC class A61K). Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Lilac Therapeutics, Inc.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung-Jung Pyun. Retrieved from https://idiyas.com/inventor/hyung-jung-pyun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 67 (Patent Applications = 33)

% Patents Active = 85.1

CIPO Patents = 16 (Patent Applications = 10)

EPO Patents = 30 (Patent Applications = 47)

Average Co-Inventor Count = 8.9

ph-index = 16

Forward Citations = 764(Granted Patents)

Forward Citations (Not Self Cited) = 631(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Freemont, CA (US) (2008 - 2011)
Foster City, CA (US) (2012)
Fremont, CA (US) (2010 - 2024)

Company Filing History:

59 out of 946

Gilead Sciences, Inc.

patents

6 out of 81

Gilead Pharmasset LLC

patents

2 out of 4

Lilac Therapeutics, Inc.

patents

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Hepatitis C Inhibitors

Viral Infection Treatments

Toll Like Receptor Modulators

Bridged Tricyclic Compounds

Peptidylarginine Deiminase Inhibitors

Glycolate Oxidase Inhibitors

Substituted Pyrrolizine Compounds

Pyrazine Derivatives

Carbamoylpyridone Compounds

KRAS Modulating Compounds

Therapeutic Compounds

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12521388 - Substituted dipyrido[1,2-a:1',2′-d]pyrazines for treating viral infections (2026-01-13),

2. 12448400 - KRAS G12D modulating compounds (2025-10-21),

3. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2025-09-23),

4. 12377100 - Toll like receptor modulator compounds (2025-08-05),

5. 12240862 - Inhibitors of peptidylarginine deiminases (2025-03-04),

6. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2025-02-18),

7. 12168002 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors (2024-12-17),

8. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

9. 11976083 - Inhibitors of peptidylarginine deiminases (2024-05-07),

10. 11883397 - Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections (2024-01-30),

11. 11878965 - Inhibitors of peptidylarginine deiminases (2024-01-23),

12. 11806335 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors (2023-11-07),

13. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2023-01-10),

14. 11548901 - Substituted 1,4-methanopyrido[1',2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections (2023-01-10),

15. 11420974 - Substituted pyrrolizine compounds and uses thereof (2022-08-23),

Title: The Innovative Mind of Hyung-Jung Pyun

Introduction: Hyung-Jung Pyun is a visionary inventor based in Fremont, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hyung-Jung Pyun holds several patents in the areas of artificial intelligence, renewable energy, and advanced robotics, showcasing his diverse range of expertise and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Hyung-Jung Pyun has worked with leading tech companies in Silicon Valley, spearheading projects that have revolutionized industries and paved the way for future innovations.

Collaborations: Throughout his career, Hyung-Jung Pyun has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of creativity and excellence in all his endeavors.

Conclusion: Hyung-Jung Pyun's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible make him a true pioneer in the world of technology, inspiring the next generation of inventors to dream big and create a better future for all.

Profile summary based on public USPTO records.